DrArifMokhtar

LCTITAN -Strength Build-up Into Resistance

Long
MYX:LCTITAN   LOTTE CHEMICAL TITAN HOLDING BERHAD
Green Arrow (Transparency = 0) = Representing Opportunity
Red Arrow (Transparency = 0) = Representing Risk
Green Arrow (Transparency = 30%) = Representing Alternate View for Opportunity, or less probable outcomes
Red Arrow (Transparency = 30%) = Representing Alternate View for Risk, or less probable outcomes

DISCLAIMER: This analysis is for educational and informational purposes only. It is based on my personal view in the market from a technical standpoint. None of information posted in this page can be used as investment decisions except for educational purpose only. Do not trade solely on the information posted in this page. Trade at your own risk and judgement. A trader could potentially lose all money. Only risk capital that can be lost without jeopardizing ones financial security of lifestyle. Please seek licensed professional guidance if you plan to invest your capital seriously.

PENAFIAN: Analysis ini hanyalah untuk tujuan pembelajaran & pendidikan sahaja dan bukan cadangan untuk membeli atau menjual stok atau apa jua jenis instrumen kewangan. Anda dinasihatkan untuk menghubungi remieser / dealer / bank pelaburan yang mempunyai lesen atau kelayakan yang sah untuk bertanyakan pendapat dan menguruskan pelaburan anda. Pelaburan dan perdagangan mempunyai risiko tinggi, dan ianya adalah Risiko Anda Sendiri.
Comment: Price went to follow my alternate prediction -> it fell down to Support Zone 1.92 - 1.96, broken the neckline of DT before rejected upward. This support zone might be tested again and if succeed, may confirm the completion Double Top Pattern. Next Support is 1.740

This company is a strong company with 5.096B Market Capitalization with 377.85M Free Cash Flow.

Next Earning is August 4.
Comment: *387.85M Free Cash Flow as of 31.07.2020 per Tradingview.com Financial.

To Join our Quantitative Analysis & Algorithmic Analytics Group : https://t.me/AMTechLeadAnalyst
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.